新型冠狀病毒感染疾病 (COVID-19) 診斷的全球市場 - 各國需求預測 (到2021年12月末，含2020年第1季、第2季)
COVID-19 Global Diagnostic Demand Outlook by Country. Assay Volume Quarterly Outlook to December 2021 Separately for Molecular and Serology. Updated to Include Q1 & Q2 2020 Actuals Data
|出版商||Howe Sound Research||商品編碼||954976|
|出版日期||內容資訊||英文 218 Pages
|新型冠狀病毒感染疾病 (COVID-19) 診斷的全球市場 - 各國需求預測 (到2021年12月末，含2020年第1季、第2季) COVID-19 Global Diagnostic Demand Outlook by Country. Assay Volume Quarterly Outlook to December 2021 Separately for Molecular and Serology. Updated to Include Q1 & Q2 2020 Actuals Data|
|出版日期: 2020年08月24日||內容資訊: 英文 218 Pages|
本報告提供全球新型冠狀病毒感染疾病 (COVID-19) 診斷市場相關調查分析，大流行進展相關3個方案為基礎，到2021年終6個季度的各國診斷需求預測相關的系統性資訊。
Can diagnostics stop an epidemic? Rapid diagnostics is key to epidemic management. But the demand is staggering. Will it stagger the diagnostics industry? This report looks at the assay volume demands by country looking out 6 quarters to the end of 2021. We look at 3 scenarios for pandemic progression and explore diagnostics demand in each scenario. A breakout of Molecular and Serology is also included. As always, our analysts are available to breakout separate numbers to meet your needs and work with your assumptions.
Our forecasts are based on the WHO Health Security Index with specific assumptions about the effectiveness of distancing measures and the impact of health system overload on different countries. These create varying timelines of demand.
All report data is available in Excel format on request.
Make projections with confidence using the latest data.
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes: